Neuroendocrine differentiation in prostate cancer: is it detectable and treatable?

Gespeichert in:

Bibliographische Detailangaben
Veröffentlicht in:	BJU international 2003-09, Vol.92 (4), p.490-490
Hauptverfasser:	Birtle, A.J., Freeman, A., Payne, H.A., Masters, J.R.W., Harland, S.J.
Format:	Artikel
Sprache:	eng
Schlagworte:	Biomarkers, Tumor - blood Chromogranin A Chromogranins - blood Humans Male Prostate-Specific Antigen - blood Prostatic Neoplasms - blood Prostatic Neoplasms - pathology
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

container_end_page	490
container_issue	4
container_start_page	490
container_title	BJU international
container_volume	92
creator	Birtle, A.J. Freeman, A. Payne, H.A. Masters, J.R.W. Harland, S.J.
description
doi_str_mv	10.1046/j.1464-410X.2003.t01-1-04376.x
format	Article
fullrecord	<record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_73586312</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>73586312</sourcerecordid><originalsourceid>FETCH-LOGICAL-c440B-30c6a461865e9161cf182b5b9663a2b32238ea1141dcf654225dbe45203b31a23</originalsourceid><addsrcrecordid>eNqVkE1PwzAMhiME4mPwF1BOu7XESRpWDiA2vjWBhEDiFqWpK2XqWkgysf17WjbgzCmO_fq1_RAyBJYCk-pkloJUMpHA3lLOmEgjgwQSJsWpSpdbZP-3vP0Ts1ztkYMQZox1CZXtkj3guWBS5vvk-REXvsWmbK13DdLSVRV6bKIz0bUNdQ19922IJiK1prHoz6gL1EVaYkQbTVEjNU1Jo0fz_bs4JDuVqQMebd4Beb25fpncJdOn2_vJ5TSxUrJxIphVRioYqQxzUGArGPEiK3KlhOGF4FyM0ABIKG2lMsl5VhYoM85EIcBwMSDDtW-34McCQ9RzFyzWtWmwXQR9KrKREtALz9dC210SPFb63bu58SsNTPdU9Uz3qHSPTfdUdUdVg_6mqpedwfFm0qKYY_nXvsHYCa7Wgk9X4-qf9nr88NpHY_EFH3yI9g</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>73586312</pqid></control><display><type>article</type><title>Neuroendocrine differentiation in prostate cancer: is it detectable and treatable?</title><source>MEDLINE</source><source>Wiley Online Library Journals Frontfile Complete</source><creator>Birtle, A.J. ; Freeman, A. ; Payne, H.A. ; Masters, J.R.W. ; Harland, S.J.</creator><creatorcontrib>Birtle, A.J. ; Freeman, A. ; Payne, H.A. ; Masters, J.R.W. ; Harland, S.J.</creatorcontrib><identifier>ISSN: 1464-4096</identifier><identifier>EISSN: 1464-410X</identifier><identifier>DOI: 10.1046/j.1464-410X.2003.t01-1-04376.x</identifier><identifier>PMID: 12930449</identifier><language>eng</language><publisher>Oxford, UK: Blackwell Publishing Ltd</publisher><subject>Biomarkers, Tumor - blood ; Chromogranin A ; Chromogranins - blood ; Humans ; Male ; Prostate-Specific Antigen - blood ; Prostatic Neoplasms - blood ; Prostatic Neoplasms - pathology</subject><ispartof>BJU international, 2003-09, Vol.92 (4), p.490-490</ispartof><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c440B-30c6a461865e9161cf182b5b9663a2b32238ea1141dcf654225dbe45203b31a23</citedby><cites>FETCH-LOGICAL-c440B-30c6a461865e9161cf182b5b9663a2b32238ea1141dcf654225dbe45203b31a23</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://onlinelibrary.wiley.com/doi/pdf/10.1046%2Fj.1464-410X.2003.t01-1-04376.x$$EPDF$$P50$$Gwiley$$H</linktopdf><linktohtml>$$Uhttps://onlinelibrary.wiley.com/doi/full/10.1046%2Fj.1464-410X.2003.t01-1-04376.x$$EHTML$$P50$$Gwiley$$H</linktohtml><link.rule.ids>314,778,782,1414,27911,27912,45561,45562</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/12930449$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Birtle, A.J.</creatorcontrib><creatorcontrib>Freeman, A.</creatorcontrib><creatorcontrib>Payne, H.A.</creatorcontrib><creatorcontrib>Masters, J.R.W.</creatorcontrib><creatorcontrib>Harland, S.J.</creatorcontrib><title>Neuroendocrine differentiation in prostate cancer: is it detectable and treatable?</title><title>BJU international</title><addtitle>BJU Int</addtitle><subject>Biomarkers, Tumor - blood</subject><subject>Chromogranin A</subject><subject>Chromogranins - blood</subject><subject>Humans</subject><subject>Male</subject><subject>Prostate-Specific Antigen - blood</subject><subject>Prostatic Neoplasms - blood</subject><subject>Prostatic Neoplasms - pathology</subject><issn>1464-4096</issn><issn>1464-410X</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2003</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNqVkE1PwzAMhiME4mPwF1BOu7XESRpWDiA2vjWBhEDiFqWpK2XqWkgysf17WjbgzCmO_fq1_RAyBJYCk-pkloJUMpHA3lLOmEgjgwQSJsWpSpdbZP-3vP0Ts1ztkYMQZox1CZXtkj3guWBS5vvk-REXvsWmbK13DdLSVRV6bKIz0bUNdQ19922IJiK1prHoz6gL1EVaYkQbTVEjNU1Jo0fz_bs4JDuVqQMebd4Beb25fpncJdOn2_vJ5TSxUrJxIphVRioYqQxzUGArGPEiK3KlhOGF4FyM0ABIKG2lMsl5VhYoM85EIcBwMSDDtW-34McCQ9RzFyzWtWmwXQR9KrKREtALz9dC210SPFb63bu58SsNTPdU9Uz3qHSPTfdUdUdVg_6mqpedwfFm0qKYY_nXvsHYCa7Wgk9X4-qf9nr88NpHY_EFH3yI9g</recordid><startdate>200309</startdate><enddate>200309</enddate><creator>Birtle, A.J.</creator><creator>Freeman, A.</creator><creator>Payne, H.A.</creator><creator>Masters, J.R.W.</creator><creator>Harland, S.J.</creator><general>Blackwell Publishing Ltd</general><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope></search><sort><creationdate>200309</creationdate><title>Neuroendocrine differentiation in prostate cancer: is it detectable and treatable?</title><author>Birtle, A.J. ; Freeman, A. ; Payne, H.A. ; Masters, J.R.W. ; Harland, S.J.</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c440B-30c6a461865e9161cf182b5b9663a2b32238ea1141dcf654225dbe45203b31a23</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2003</creationdate><topic>Biomarkers, Tumor - blood</topic><topic>Chromogranin A</topic><topic>Chromogranins - blood</topic><topic>Humans</topic><topic>Male</topic><topic>Prostate-Specific Antigen - blood</topic><topic>Prostatic Neoplasms - blood</topic><topic>Prostatic Neoplasms - pathology</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Birtle, A.J.</creatorcontrib><creatorcontrib>Freeman, A.</creatorcontrib><creatorcontrib>Payne, H.A.</creatorcontrib><creatorcontrib>Masters, J.R.W.</creatorcontrib><creatorcontrib>Harland, S.J.</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><jtitle>BJU international</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Birtle, A.J.</au><au>Freeman, A.</au><au>Payne, H.A.</au><au>Masters, J.R.W.</au><au>Harland, S.J.</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Neuroendocrine differentiation in prostate cancer: is it detectable and treatable?</atitle><jtitle>BJU international</jtitle><addtitle>BJU Int</addtitle><date>2003-09</date><risdate>2003</risdate><volume>92</volume><issue>4</issue><spage>490</spage><epage>490</epage><pages>490-490</pages><issn>1464-4096</issn><eissn>1464-410X</eissn><cop>Oxford, UK</cop><pub>Blackwell Publishing Ltd</pub><pmid>12930449</pmid><doi>10.1046/j.1464-410X.2003.t01-1-04376.x</doi><tpages>1</tpages><oa>free_for_read</oa></addata></record>
fulltext	fulltext
identifier	ISSN: 1464-4096
ispartof	BJU international, 2003-09, Vol.92 (4), p.490-490
issn	1464-4096 1464-410X
language	eng
recordid	cdi_proquest_miscellaneous_73586312
source	MEDLINE; Wiley Online Library Journals Frontfile Complete
subjects	Biomarkers, Tumor - blood Chromogranin A Chromogranins - blood Humans Male Prostate-Specific Antigen - blood Prostatic Neoplasms - blood Prostatic Neoplasms - pathology
title	Neuroendocrine differentiation in prostate cancer: is it detectable and treatable?
url	https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-15T10%3A22%3A56IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Neuroendocrine%20differentiation%20in%20prostate%20cancer:%20is%20it%20detectable%20and%20treatable?&rft.jtitle=BJU%20international&rft.au=Birtle,%20A.J.&rft.date=2003-09&rft.volume=92&rft.issue=4&rft.spage=490&rft.epage=490&rft.pages=490-490&rft.issn=1464-4096&rft.eissn=1464-410X&rft_id=info:doi/10.1046/j.1464-410X.2003.t01-1-04376.x&rft_dat=%3Cproquest_cross%3E73586312%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=73586312&rft_id=info:pmid/12930449&rfr_iscdi=true